ZVRA
NASDAQStockZevra Therapeutics, Inc.
$10.24-0.17 (-1.63%)
52-Week Range
$6.56
$12.79
Key Stats
Market Cap
576.5M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.94
Volume
1.1M
Avg Volume
1.7M
Performance
1M
+18.29%
3M
+22.27%
6M
+40.87%
YTD
+22.12%
1Y
+28.60%
3Y
+129.39%
5Y
+91.09%
Price Chart
ETF Exposure
ZVRA is held by 37 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SURI | Simplify Propel Opportunities ETF | 1.55% |
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 1.46% |
| LITL | Simplify Piper Sandler US Small-Cap PLUS Income ETF | 0.83% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.29% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.21% |
| IWC | iShares Micro-Cap ETF | 0.13% |
| EES | WisdomTree U.S. SmallCap Fund | 0.09% |
| IBB | iShares Biotechnology ETF | 0.05% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.04% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.03% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.03% |
| DFAS | Dimensional - US Small Cap ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.02% |
| RSSL | Global X - Russell 2000 ETF | 0.02% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
About ZVRA ETF Exposure
Zevra Therapeutics, Inc. (ZVRA) is held by 37 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 576.5M, ZVRA is a widely held institutional stock. The stock currently trades at $10.24. Investors can gain exposure to ZVRA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ZVRA, sorted by portfolio weight.